Active Pharmaceutical Ingredients (API) Market Size to Reach Revenues of USD 266.80 Billion by 2026 - Arizton

News provided by

Oct 26, 2021, 09:00 ET

CHICAGO, Oct. 26, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this global active pharmaceutical ingredients (API) market report.

The active pharmaceutical ingredients (API) market is expected to grow at a CAGR of over 6.22% during the period 2020−2026.

Key Highlights Offered in the Report:

APAC dominated the global active pharmaceutical ingredient market followed by North America in 2020. APAC region will remain the manufacturing hub for APIs during the forecast period and is expected to grow at a CAGR of more than 6%.
Oncology is the largest segment in the global active pharmaceutical ingredient market, growing with a CAGR of more than 7% in forecast period. The market is further being driven by the rising investments by several biotech and pharmaceutical companies in anti-cancer drug discovery and development.
The biopharmaceutical industry is expanding globally and is witnessing a large number of mergers and acquisitions. These agreements include companies and deals structured around essential services in the supply chain such as manufacturing, pharmacy benefit, patent protection, and distribution network.
Internet penetration and increase in demand for over-the-counter medicines are amplifying the growth of the market. Manufacturers should make sure that information about their APIs is available on the internet.
Manufacturers must focus on optimizing the global supply chain as the demand for pharmaceutical products has increased globally. The aging population and increasing cases of chronic diseases are expected to fuel the market growth.

Key Offerings:

Market Size & Forecast by Revenue | 2020−2026
Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
Market Segmentation – A detailed analysis by application, molecule type, type of manufacturers, type of drugs, synthesis type, and geography
Competitive Landscape – 5 key vendors and 20 other vendors

Get your sample today! https://www.arizton.com/market-reports/active-pharmaceutical-ingredients-market

Active Pharmaceutical Ingredients (API) Market – Segmentation

Oncology APIs refer to the biologically active components present in anti-cancer drugs. The growing incidences of cancer coupled with the rising number of R&D activities pertaining to anti-cancer drugs are primarily driving the market for oncology APIs. Moreover, the increasing awareness towards the improved efficacy of various APIs on targeted cancerous cells is also propelling the demand for oncology drugs.
Large molecules or biologics are proteins used in drug development. In contrast to small molecule drugs, most large molecule drugs are complex and composed of more than 1,300 amino acids that are identical versions of human proteins. Large molecules stay in the bloodstream for longer than small molecules.
Captive manufacturing is a process of manufacturing APIs in-house. There are a lot of benefits and shortcomings of producing APIs in-house. COVID-19 has fueled the need for producing APIs in-house rather than outsourcing due to disruptions in the supply chain in China.

Active Pharmaceutical Ingredients (API) Market by Application

Oncology
Cardiovascular Disease
Anti-infectives
Central Nervous System
Respiratory diseases
Diabetes
Pain management
Others

Active Pharmaceutical Ingredients (API) Market by Molecule Type

Small
Large

Active Pharmaceutical Ingredients (API) Market by Type of manufacturers

Captive
Merchant

Active Pharmaceutical Ingredients (API) Market by Type of Drugs

Prescription
Over the counter

Active Pharmaceutical Ingredients (API) Market by Synthesis Type

Synthetic
Biotech

Active Pharmaceutical Ingredients (API) Market – Dynamics

The biopharmaceutical industry is expanding globally and is witnessing a large number of mergers and acquisitions. These agreements include companies and deals structured around essential services in the supply chain such as manufacturing, pharmacy benefit, patent protection and distribution network. Mergers and acquisition deals are centered on assets or technologies belonging to other ancillary healthcare and life sciences industry. The mergers and acquisitions strategy involves the active management of products and capabilities, ensuring that the internal investment in research and development and commercial activities helps in mitigating risks and delivering predictable returns. They are done to acquire assets that are complementary to an existing franchise, such as sequential or combination drug treatments. Acquisition strategies help in executing problems related to portfolio strategy, tapping into external innovation, and delivering investor return.

Key Drivers and Trends fueling Market Growth:

Growing Demand for Generic Drugs
Increasing Digitalization in Healthcare
Invention of New Generation APIs
Growth in API Outsourcing Operations

Active Pharmaceutical Ingredients (API) Market – Geography

The North American active pharmaceutical ingredients market is currently driven by several factors. Growing geriatric population and increasing incidence of cancer and diabetes have escalated the demand for APIs during the forecast period. US government expenditure on healthcare facilities has increased significantly, propelling the market growth. Manufacturers have increased their investments in R&D for developing better-quality APIs as it directly affects the safety and efficacy of the drug. Moreover, technological advancements of the new generation of APIs also amplifies market growth. The North American APIs market is anticipated to witness high growth during the forecast period. Many CMOs present in API manufacturing have identified the need for advance generic drugs.

Get your sample today! https://www.arizton.com/market-reports/active-pharmaceutical-ingredients-market

Geography

North America

US
Canada

Europe

United Kingdom
Germany
France
Italy
Spain
Russia

APAC

China
India
Indonesia
Japan
Singapore

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
UA

Major Vendors

Pfizer Inc.
Cipla Inc.
Novartis AG
Mylan N.V.
Sun Pharmaceuticals Industries Ltd.

Other Prominent Vendors

Albemarle Corporation
AbbVie Inc.
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Company
Teva Pharmaceuticals Industries Ltd.
Bristol-Myers Squibb
Aurobindo Pharma limited
Sanofi
Boehringer Ingelheim International GmbH
BASF SE
Lupin
Shenzhen Hepalink Pharmaceutical Group Ltd.
Abbott
Biocon
Amgen Inc.
GlaxoSmithKline Plc
Hoffmann-La Roche Ltd.
Merck KGaA
Viatris Inc.,
Glenmark Pharmaceuticals

Explore our healthcare & lifesciences profile to know more about the industry.

Read some of the top-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare, and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Mail: [email protected]
Call: +1-312-235-2040
+1 302 469 0707

SOURCE Arizton Advisory & Intelligence